G-CSF treatment can attenuate dexamethasone-induced reduction in C2C12 myotube protein synthesis. Issue 1 (May 2015)

• Record Type: Journal Article
• Authors: Wright, Craig R.; Brown, Erin L.; Ward, Alister C.; Russell, Aaron P.
• Is Part Of: Cytokine. Volume 73:Issue 1(2015)
• Page Start: 1
• Page End: 7
• Publication Date: 2015-05
• Subjects: Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2015.01.012
• Languages: English
• ISSNs: 1043-4666

Abstract

<abstract xml:lang="en" abstract-type="author-highlights" id="ab005"> <title id="st065">Highlights</title> <sec> <p id="sp0005"> <list id="l0005"> <list-item id="o0005"> <label></label> <p id="p0120">Moderate dose G-CSF attenuates dexamethasone (DEX) reduced protein synthesis.</p> </list-item> <list-item id="o0010"> <label></label> <p id="p0125">High does G-CSF exacerbates the DEX induced reduction in protein synthesis.</p> </list-item> <list-item id="o0015"> <label></label> <p id="p0130">G-CSF does not affect protein degradation under basal or dexamethasone.</p> </list-item> <list-item id="o0020"> <label></label> <p id="p0135">G-CSF did not increase phosphorylation of Akt, STAT3, Erk1/2, Src, Lyn or Erk5.</p> </list-item> </list> </p> </sec> </abstract>